Amy E. Bryant
About
Amy E. Bryant is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Neurology.
According to data from OpenAlex, Amy E. Bryant has authored 86 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 55 papers in Public Health, Environmental and Occupational Health and 18 papers in Neurology. Recurrent topics in Amy E. Bryant's work include Streptococcal Infections and Treatments (55 papers), Antimicrobial Resistance in Staphylococcus (35 papers) and Clostridium difficile and Clostridium perfringens research (35 papers). Amy E. Bryant is often cited by papers focused on Streptococcal Infections and Treatments (55 papers), Antimicrobial Resistance in Staphylococcus (35 papers) and Clostridium difficile and Clostridium perfringens research (35 papers). Amy E. Bryant collaborates with scholars based in United States, Australia and China. Amy E. Bryant's co-authors include Dennis L. Stevens, Michael J. Aldape, Julian I. Rood, Milena M. Awad, Clifford R. Bayer, Eric R. McIndoo, Yongsheng Ma, Sean P. Hackett, Rodney K. Tweten and S. M. Hamilton and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and PLoS ONE.
In The Last Decade
Amy E. Bryant
83 papers receiving 4.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Amy E. Bryant United States | 36 | 2.7k | 2.2k | 725 | 680 | 592 | 86 | 4.1k | ||
| Graziella Orefici Italy | 39 | 2.0k 0.7× | 1.6k 0.7× | 336 0.5× | 909 1.3× | 1.9k 3.3× | 147 | 4.6k | ||
| Anna Norrby‐Teglund Sweden | 48 | 3.7k 1.4× | 4.6k 2.0× | 1.2k 1.6× | 963 1.4× | 1.6k 2.6× | 126 | 7.4k | ||
| Shiranee Sriskandan United Kingdom | 41 | 1.9k 0.7× | 2.3k 1.0× | 451 0.6× | 718 1.1× | 1.1k 1.9× | 154 | 4.6k | ||
| John K. McCormick Canada | 37 | 2.2k 0.8× | 1.2k 0.5× | 388 0.5× | 1.9k 2.8× | 839 1.4× | 99 | 5.5k | ||
| Tadahiro Karasawa Japan | 33 | 1.3k 0.5× | 550 0.2× | 272 0.4× | 551 0.8× | 569 1.0× | 70 | 2.7k | ||
| Barry J. Hartman United States | 17 | 2.1k 0.8× | 649 0.3× | 508 0.7× | 817 1.2× | 1.8k 3.1× | 34 | 4.5k | ||
| Lewis W. Wannamaker United States | 38 | 1.9k 0.7× | 3.2k 1.4× | 464 0.6× | 1.5k 2.2× | 1.3k 2.3× | 139 | 5.9k | ||
| Joseph D. Schwartzman United States | 41 | 1.1k 0.4× | 723 0.3× | 516 0.7× | 827 1.2× | 2.3k 3.8× | 95 | 5.4k | ||
| Yves Gillet France | 26 | 2.4k 0.9× | 1.0k 0.5× | 896 1.2× | 950 1.4× | 1.3k 2.2× | 108 | 3.5k | ||
| Rudolf Lütticken Germany | 34 | 1.2k 0.4× | 1.5k 0.6× | 357 0.5× | 388 0.6× | 1.2k 2.0× | 113 | 3.4k |
Countries citing papers authored by Amy E. Bryant
Since
Specialization
Citations
This map shows the geographic impact of Amy E. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Bryant more than expected).
Fields of papers citing papers by Amy E. Bryant
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Amy E. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Bryant. The network helps show where Amy E. Bryant may publish in the future.
Co-authorship network of co-authors of Amy E. Bryant
This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Bryant. A scholar is included among the top collaborators of Amy E. Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Bryant. Amy E. Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mei, Qi, Guangyuan Hu, Yang Yang, et al.. (2022). Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study. Journal for ImmunoTherapy of Cancer. 10(3). e004157–e004157.
2.
Mei, Qi, Ying Wang, Amy E. Bryant, et al.. (2020). Development and validation of prognostic model for predicting mortality of COVID-19 patients in Wuhan, China. Scientific Reports. 10(1). 22451–22451.
3.
Bryant, Amy E., Clifford R. Bayer, Michael J. Aldape, Eric R. McIndoo, & Dennis L. Stevens. (2020). Emerging erythromycin and clindamycin resistance in group A streptococci: Efficacy of linezolid and tedizolid in experimental necrotizing infection. Journal of Global Antimicrobial Resistance. 22. 601–607.
4.
Aldape, Michael J., et al.. (2018). Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection. International Journal of Antimicrobial Agents. 52(4). 469–473.
5.
Bryant, Amy E., et al.. (2017). Effects of Iclaprim and Trimethoprim on Exotoxin Production by Methicillin-resistant Staphylococcus aureus. Open Forum Infectious Diseases. 4(suppl_1). S372–S373.
6.
Bryant, Amy E., Clifford R. Bayer, Michael J. Aldape, & Dennis L. Stevens. (2015). The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections. Current Opinion in Infectious Diseases. 28(3). 231–239.
7.
Hamilton, S. M., Dennis L. Stevens, & Amy E. Bryant. (2013). Pregnancy-Related Group A Streptococcal Infections: Temporal Relationships Between Bacterial Acquisition, Infection Onset, Clinical Findings, and Outcome. Clinical Infectious Diseases. 57(6). 870–876.
8.
Aldape, Michael J., Amy E. Bryant, Eva J. Katahira, et al.. (2009). Innate immune recognition of, and response to, Clostridium sordellii. Anaerobe. 16(2). 125–130.
9.
Varshney, Avanish K., Luis R. Martinez, Stephanie M. Hamilton, et al.. (2009). Augmented Production of Panton‐Valentine Leukocidin Toxin in Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusIs Associated with Worse Outcome in a Murine Skin Infection Model. The Journal of Infectious Diseases. 201(1). 92–96.
10.
Hamilton, S. M., Amy E. Bryant, Karen C. Carroll, et al.. (2007). In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections. Clinical Infectious Diseases. 45(12). 1550–1558.
11.
Aldape, Michael J., Amy E. Bryant, & Dennis L. Stevens. (2006). Clostridium sordellii Infection: Epidemiology, Clinical Findings, and Current Perspectives on Diagnosis and Treatment. Clinical Infectious Diseases. 43(11). 1436–1446.
12.
Stevens, Dennis L., et al.. (2006). Impact of Antibiotics on Expression of Virulence‐Associated Exotoxin Genes in Methicillin‐Sensitive and Methicillin‐ResistantStaphylococcus aureus. The Journal of Infectious Diseases. 195(2). 202–211.
13.
Stevens, Dennis L., et al.. (2004). Immunization with the C‐Domain of α‐Toxin Prevents Lethal Infection, Localizes Tissue Injury, and Promotes Host Response to Challenge withClostridium perfringens. The Journal of Infectious Diseases. 190(4). 767–773.
14.
Bryant, Amy E., et al.. (2003). Activation of Platelet gpIIbIIIa by Phospholipase C fromClostridium perfringensInvolves Store‐Operated Calcium Entry. The Journal of Infectious Diseases. 187(3). 408–417.
15.
Bryant, Amy E., et al.. (2003). M Type 1 and 3 Group A Streptococci Stimulate Tissue Factor-Mediated Procoagulant Activity in Human Monocytes and Endothelial Cells. Infection and Immunity. 71(4). 1903–1910.
16.
Bryant, Amy E., et al.. (1999). Type‐Specific Opsonophagocytosis of Group A Streptococcus by Use of a Rapid Chemiluminescence Assay. The Journal of Infectious Diseases. 179(5). 1293–1296.
17.
Stevens, Dennis L., Amy E. Bryant, Sean P. Hackett, et al.. (1996). Group A Streptococcal Bacteremia: The Role of Tumor Necrosis Factor in Shock and Organ Failure. The Journal of Infectious Diseases. 173(3). 619–626.
18.
Stevens, Dennis L., et al.. (1993). Penicillin-Binding Protein Expression at Different Growth Stages Determines Penicillin Efficacy In Vitro and In Vivo: An Explanation for the Inoculum Effect. The Journal of Infectious Diseases. 167(6). 1401–1405.
19.
Bryant, Amy E., Michael Kehoe, & Dennis L. Stevens. (1992). Streptococcal Pyrogenic Exotoxin A and Streptolysin O Enhance Polymorphonuclear Leukocyte Binding to Gelatin Matrixes. The Journal of Infectious Diseases. 166(1). 165–169.
20.
Stevens, Dennis L., Amy E. Bryant, & Sean P. Hackett. (1992). Gram-positive shock. Current Opinion in Infectious Diseases. 5(3). 355–363.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Graziella Orefici Breakdown of academic impact, for papers by Anna Norrby‐Teglund Breakdown of academic impact, for papers by Shiranee Sriskandan Breakdown of academic impact, for papers by John K. McCormick Breakdown of academic impact, for papers by Tadahiro Karasawa Breakdown of academic impact, for papers by Barry J. Hartman Breakdown of academic impact, for papers by Lewis W. Wannamaker Breakdown of academic impact, for papers by Joseph D. Schwartzman Breakdown of academic impact, for papers by Yves Gillet Breakdown of academic impact, for papers by Rudolf Lütticken